Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database of Systematic Reviews 2017, Issue 1.

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

VYVGART is the first and only targeted IgG Fc-antibody fragment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and the first novel mechanism of action for CIDP treatment in more than ...

ABSTRACT: Chronic inflammatory demyelinating polyneuropathy (CIDP) with nerve root hypertrophy is a relatively common association, reported in approximately 16 - 54% of cases based on imaging studies.

VandenBergh, P.Y.K., et al. (2021) European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Report of a ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) diagnoses are frequently missed or delayed and standard treatments -- intravenous immunoglobulin (IVIG), steroids, and plasma exchange ...

Ulcerative colitis is one of the most common chronic inflammatory bowel diseases. Its incidence is increasing worldwide—especially in industrialized countries.

About this study The purpose of this study is to assess the effect of TAK-411 on disability in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). More formally, the ...